In the system of management and monitoring of diabetes mellitus, sugarated hemoglobin is an important and decisive indicator. It provides doctors and patients with diabetes with a comprehensive and accurate perspective to assess the overall control of blood sugar levels over a period of time, which is invaluable.
Hemoglobin glucose is the product of a slow and irreversible non-enzyme reaction in human blood cells. The erythrocyte survives about 120 days in the blood cycle, so that the sugared haemoglobin reflects the average blood sugar levels over the past two to three months. Unlike the daily monitored immediate blood sugar indicators such as empty abdominal sugar and post-eating blood sugar, it does not fluctuate sharply due to a diet, physical activity or short-term stress, allowing for a more stable and reliable average of haemorrhagic sugar over a longer period of time.
For diabetics, the values of sugared haemoglobin are like a mirror that clearly reflects the good and poor management of blood sugar. Most diabetics should keep the sugared hemoglobins below 7 per cent, while some diabetes patients with lower conditions, longer life expectancy and no apparent cardiovascular disease complications can be more closely targeted at less than 6.5 per cent. When diabetes patients are able to stay within the target range through a combination of sound dietary planning, regular physical exercise, standard drug treatment and good self-remograss monitoring, this means that they have had relatively low and stable blood sugar fluctuations over the past few months. Long-term stable blood sugar levels help to protect the microvascular system and reduce the incidence of microvascular complications such as diabetes kidneys, diabetes retinasis, etc. At the same time, the risk of major vascular diseases such as coronary heart disease and cerebrovascular diseases can be reduced, thus improving the quality of life and life expectancy of diabetes patients.
Conversely, if the results of the smelting haemoglobin test go beyond the desired range, this is no doubt a dangerous signal that diabetes patients have had poor blood sugar control over the past period and that there are high fluctuations in blood sugar levels. The high blood sugar environment can cause direct damage to vascular inner-skin cells, contributing to the formation and development of avial porridges, leading to reduced vascular narrowness and resilience, affecting blood circulation and increasing the risk of cardiovascular events. In microvasculars, long-term high blood sugar increases the size of the pelvis base base of the kidney ball and causes diabetes; it can also cause damage to retina vasculars, resulting in loss of sight and even blindness.
As a key indicator for the assessment of blood sugar control levels, erythroglobin sugar is central to the treatment and management of diabetes. Diabetes patients should be fully aware of their importance and actively cooperate with doctors in their efforts to keep the sugared hemoglobins within their desired range through a comprehensive health management strategy, so as to effectively prevent the occurrence of diabetes complications and provide a solid guarantee of their health and quality of life.
